生物活性胜肽市場：依原料、治療領域、通路和地區分類

Bioactive Peptide Market, By Source, By Therapeutic Area, By Distribution Channel, By Geography

出版日期: 2026年02月23日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，生物活性胜肽市場規模將達到70.896億美元，到2033年將達到133.28億美元。預計從2026年到2033年，其複合年成長率將達到9.4%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	7,089,600,000 美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	9.40%	2033年市場規模預測：	133.28億美元

生物活性胜肽是一類生物分子，通常嵌入母體蛋白質的結構中，並在蛋白質被切割後被活化。另一類胜肽則由許多微生物主動產生和表現。許多生物活性胜肽透過化學或重組技術進行市場推廣。生物活性胜肽能夠補充蛋白質和其他必需營養素，進而提升食品的營養價值。由於其對健康的許多益處，例如預防和控制心血管疾病、糖尿病、癌症和感染疾病等慢性疾病，生物活性胜肽正日益受到關注。因此，生物活性胜肽也被用於治療方法大腸激躁症等功能性疾病，預計這將推動市場成長。

市場動態

主要市場參與者活性化對肺水腫和類風濕性關節炎治療的研發投入，預計將推動全球生物活性胜肽市場在預測期內成長。例如，2022年5月30日，生物技術公司APEPTICO Forschung und Entwicklung GmbH宣布，由APEPTICO主導的國際科學家網路已闡明了索魯那肽（一種合成肽乾粉吸入劑和吸入氣霧劑製劑）的3D結構和作用機制，該藥物是治療肺水腫的候選藥物。

同樣，在2020年成功完成1a期臨床試驗後，臨床階段生物技術公司Oryn Therapeutics於2021年6月類風濕性關節炎招募患者，進行一項隨機、雙盲、對照、重複劑量比較的1b期臨床試驗，受試者為使用DMARD（類風濕性關節炎緩解疾病抗風濕藥）治療的類風濕性關節炎（RA）患者。

本報告的主要特點

本報告指出了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
本節根據以下參數，介紹全球生物活性胜肽市場中主要企業的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
《全球生物活性胜肽市場》報告面向該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過分析全球生物活性胜肽市場中使用的各種策略矩陣來促進決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 亞太其他地區
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

熱圖分析
公司簡介
- Archer Daniels Midland Company
- Seagarden AS
- Phermpep Co. Ltd.
- Arlak Biotech Pvt. Ltd.
- Naturade
- Royal DSM
- MYOS RENS Technology Inc.
- Natural Factors Inc.
- Valio Oy
- GenScript
- HELIX BIOMEDIX
- Oryn Therapeutics
- Selecta Biosciences
- NIBEC
- vivitide
- PEPTIDE INSTITUTE, INC
- BCN Peptides
- Setlance srl.
- APEPTICO Forschung und Entwicklung GmbH
- BIONANOPLUS

第9章

參考
分析方法
關於 Coherent Market Insights

簡介目錄

Product Code: CMI3018

Bioactive Peptide Market is estimated to be valued at USD 7,089.6 Mn in 2026 and is expected to reach USD 13,328.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.4% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 7,089.6 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	9.40%	2033 Value Projection:	USD 13,328.0 Mn

Bioactive peptides are a group of biological molecules that are normally buried in the structure of parent proteins and become active after the cleavage of the proteins. Another group of peptides is actively produced and found in many microorganisms. Many groups of bioactive peptides have been marketed chemically or recombinantly. The bioactive peptides are ingredients that provide nutritive value to the food by adding protein and other important nutrients. Bioactive peptides are gaining popularity, owing to health benefits such as prevention and control of chronic disease conditions like cardiovascular disease, diabetes, cancer, and infectious diseases. Therefore, bioactive peptides are used as treatment therapy for most of the functional disorders such as irritable bowel disease, which is expected to drive the market growth.

Market Dynamics

Increasing research and development by key market players for the treatment of pulmonary edema and rheumatoid arthritis is expected to drive growth of the global bioactive peptide market over the forecast period. For instance, on May 30, 2022, APEPTICO Forschung und Entwicklung GmbH, a biotechnology company, announced that the 3-D structure and the mechanism of action of Solnatide,( a dry powder inhalation and an inhaled aerosol formulation of a synthetic peptide) a possible treatment for pulmonary oedema, had been disclosed by an international network of scientists led by APEPTICO.

Similarly, in June 2021, Oryn Therapeutics, a clinical stage biotechnology company, had opened recruitment for rheumatoid arthritis patients for a Phase 1b clinical trial, which was a Randomized, Double-blind, Vehicle Controlled, and Repeat Dose Comparative Study in RA (rheumatoid arthritis) Patients Managed with DMARDs (Disease-modifying antirheumatic drugs), whereas the Phase 1a clinical trial study had been successfully completed in 2020.

Key features of the study

This report provides in-depth analysis of the global bioactive peptide market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2022 - 2030, considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global bioactive peptide market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include, Archer Daniels Midland Company, Seagarden AS, Phermpep Co. Ltd., Arlak Biotech Pvt. Ltd., Naturade, Royal DSM, MYOS RENS Technology Inc., Natural Factors Inc., Valio Oy, GenScript, HELIX BIOMEDIX, Oryn Therapeutics, Selecta Biosciences, NIBEC, vivitide, PEPTIDE INSTITUTE, INC, BCN Peptides, Setlance srl., APEPTICO Forschung und Entwicklung GmbH, and BIONANOPLUS
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global bioactive peptide market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, suppliers, research and consulting firms, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global bioactive peptide market

Market Segmentation

By Source
- Plant
- Milk
- Egg
- Meat
- Fish
- Others (Bacterial Antimicrobial Peptides, Venom Peptidomics)
By Therapeutic Area
- Antihypertensive
- Antioxidant
- Immunostimulatory
- Antimicrobial
- Diabetes
- Others (Gastrointestinal System, Cardiovascular System)
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others (Drug Store, Mail-Order Pharmacy)
By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
Key Players
- Archer Daniels Midland Company
- Seagarden AS
- Phermpep Co. Ltd.
- Arlak Biotech Pvt. Ltd.
- Naturade
- Royal DSM
- MYOS RENS Technology Inc.
- Natural Factors Inc.
- Valio Oy, GenScript
- HELIX BIOMEDIX
- Oryn Therapeutics
- Selecta Biosciences
- NIBEC
- Vivitide
- PEPTIDE INSTITUTE, INC
- BCN Peptides
- Setlance srl.
- APEPTICO Forschung und Entwicklung GmbH
- BIONANOPLUS

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
Market Definition and Scope
Executive Summary
- Market Snapshot, By Source
- Market Snapshot, By Therapeutic Area
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Key Development
Regulatory Scenario
Reimbursement Scenario
Pest Analysis
Market Potential in Lower economies

4. Global Bioactive Peptide Market, By Source, 2026 - 2033, (US$ Million)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Plant
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
Milk
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
Egg
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
Meat
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
Fish
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
Others (Bacterial Antimicrobial Peptides and Venom Peptidomics)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)

5. Global Bioactive Peptide Market, By Therapeutic Area, 2026 - 2033, (US$ Million)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026- 2033
- Segment Trends
Antihypertensive
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
Antioxidant
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
Immunostimulatory
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
Antimicrobial
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
Diabetes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
Others (Gastrointestinal System and Cardiovascular System)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)

6. Global Bioactive Peptide Market, By Distribution Channel, 2026 - 2033, (US$ Million)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
Others (Drug Store and Mail-Order Pharmacy)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)

7. Global Bioactive Peptide Market, By Region, 2026 - 2033, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (US$ Million)
  - North Africa
  - Central Africa
  - South Africa